资源描述:
《甲胎蛋白异质体3、高尔基体蛋白73及热休克蛋白27在原发性肝癌中的诊断价值-肿瘤医学论文》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、甲胎蛋白异质体3.高尔基体蛋白73及热休克蛋白27在原发性肝癌中的诊断价值•肿瘤医学论文甲胎蛋白异质体3,高尔基体蛋白73及热休克蛋白27在原发性肝癌中的诊断价值黄琳淋李光迪兰州大学第二临床医学院,甘肃兰州730030[摘要]目的探讨甲胎蛋白异质体3(AFP-L3X高尔基体蛋白73(GP73)、热休克蛋白27(HSP27)在原发性肝癌患者中的诊断价值。方法收集98例患者血清,其中原发性肝癌36例”肝转移癌14例,胃癌20例,健康对照28例z采用电化学发光法检测AFP,采用酶联免疫吸附试剂盒检测各
2、组血清中AFP-L3.HSP27、GP73的表达情况。结果AFP、AFP-L3.GP73.HSP27在原发性肝癌组的表达情况明显高于肝转移癌组、胃癌组及健康对照组,明显差异有统计学意义(P0.01)。通过受试者工作特征曲线(ROC)评价作图,AFP、AFP-L3.GP73及HSP27曲线下面积分别为:0.969、0.977、0.978、0.985。AFP-L3.GP73及HSP27与AFP的相关性为0.896、0.853、0.838(P0.05);AFP、AFP-L3.GP73及HSP27与乙肝
3、表面抗原的相关性为0.076、0.119.0.176、0.176(P0.05结论AFP-L3.HSP27、GP73均可以作为原发性肝癌的肿瘤标记物,与AFP相比,具有更高的诊断价值,它们与表面抗原的表达情况无关。关键词原发性肝癌;肿瘤标记物;甲胎蛋白异质体3;热休克蛋白27;高尔基体蛋白73[中图分类号]R735.7[文献标识码]A[文章编号]1674-0742(2013)05(a)0026-03ValuesofAlpha-fetoprotein・L$GolgiProtein73andHeat
4、shockProtein27intheDiagnosisofPrimaryHepaticCarcinomaHUANGLinlinLIGuangdiTheSecondClinicalMedicalCollegeofLanzhouUnicersityinGansuprovince,Lanzhou730030,China[Abstract]AimDiscussthevaluesofAlpha-fetoprotein・L3,Golgiprotein73andHeatshockprotein27inthe
5、diagnosisofprimaryhepaticcarcinoma.MethodsAFPwasmeasuredbyelectro-chemiluminesceneeimmunoassay.Enzyme-linkedimmunosorbentassay(ELISA)wasusedtodetecttheserumlevelofAFP-L3,HSP27ZGP73in36casesofprimaryhepaticcarcinomaz14casesofmetastaticlivercancerz20ca
6、sesofgastriccancerand28casesofhealthycontrol.ResultsSerumAFBAFP-L3ZHSP27ZGP73weresignificantlyhigherinpatientswithprimaryhepaticcarcinomacomparedwithothergroups(P0.05).AreasundertheROCcurvesofAFBAFP-L3zHSP27zGP73were0.969z0.977z0.978z0.985.Thecorrela
7、tionbetweenAFPandAFP-L3/HSP27ZGP73were0.896/0.853/0.838(P0.05).thecorrelationbetweenHBVSAgandAFBAFP-L3ZHSP27ZGP73were0.119,0.176,0.176.(P0.05).ConclusionAFP-L3/HSP27,GP73couldbeusedasbiomarkersinthediagnosisofprimaryhepaticcarcinoma,comparedwithAFRth
8、eyhavebettervaluesjthasnocorrelationwithHBVSAg.[Keywords]Primaryhepaticcarcinoma;Biomarkers;Alpha-fetoprotein・L3;Golgiprotein73;Heatshockprotein27原发性肝癌(primarylivercancer)是我国常见的消化系统恶性肿瘤,由于起病隐匿,发展迅速,确诊时多数患者已经处于癌症晚期,治疗效果不佳,死亡率高,每年有100万肝癌新患者,有11万人死于肝癌z其